Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancersChunhong Hu, Fang Wu, Xiaohan Liu et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 77
Expert consensus on treatment for stage III non‐small cell lung cancerYi‐Long Wu, Yun Fan, Shun Lü et al.|Medicine Advances|2023Cited by 18
Circulating tumor DNA as markers of dynamic recurrence risk and adjuvant chemotherapy benefit in resected non-small cell lung cancer.Wei Guo, Shugeng Gao, Fang Lv et al.|Journal of Clinical Oncology|2021Cited by 2